1042
I. Car6alho et al. / Carbohydrate Research 338 (2003) 1039–1043
169.4 (COCH2Ph), 156.8 (CO Fmoc), 144.0, 141.3
(Cquat. Fmoc Ph), 135.5 (Cquat. OCH2Ph), 128.6,
128.5, 128.3, 127.7, 127.1, 125.5, 119.9 (CH Ph), 98.5
(C-1), 74.5 (bCHThr), 71.9, 71.7 (C-5, C-3), 68.5 (C-4),
67.3 (OCH2Ph, CH2 Fmoc), 61.9 (C-6), 58.7
(aCHThr), 55.3 (C-2), 47.3 (CH Fmoc), 23.3, 20.7,
20.5, 20.6 (COCH3), 17.0 (CH3 Thr). ESIMS found
m/z 778.3187 [M+NH+4 ]. Calcd for C40H44N2O13·NH4
778.3187.
−14.4 (c 1, in MeOH)(Lit.,9 [h]D+14.7); Rf 0.55
[CHCl3–MeOH (30:1)]; lH (CDCl3, 270 MHz) 7.73 (2
H, d, J 7.3, CH Fmoc Ph), 7.61 (2 H, d, J 6.6, CH
Fmoc Ph), 7.38–7.24 (4 H, m, CH Fmoc Ph), 6.12 (1
H, d, J 9.2, NH), 6.03 (1 H, d, J 9.2, NH), 5.26 (1 H,
t, J2,3 9.6, H-3), 5.09 (1 H, t, J3,4 9.6, H-4), 4.64 (1 H,
d, J1,2 8.3, H-1), 4.50–3.60 (9 H, m, CH2 Fmoc, 2 CH
Thr, H-6, CH Fmoc, H-6%, H-2, H-5), 2.04, 1.98, 1.97,
1.93 (12 H, m, COCH3), 1.18 (3 H, d, J 6.3, CH3 Thr);
lC (CDCl3, 67.5 MHz) 171.3, 170.9, 170.8, 169.3
(COCH3), 156.8 (CO Fmoc), 143.7, 141.1 (Cquat.),
127.6, 127.0, 125.1, 119.9 (CH Ph), 99.4 (C-1), 71.7,
71.5, 70.9, 68.2, 67.3 (C-3, C-4, C-5, 2 CH Thr, CH2
Fmoc), 62.0 (C-6), 52.3 (C-2), 47.0 (CH Fmoc), 22.9,
20.8, 20.7, 20.5 (COCH3), 17.3 (CH3 Thr) (NMR data
in accord with the literature20); ESIMS found m/z
671.2453 [M+NH+4 ]. Calcd for C40H44N2O13 671.2452.
The optical rotation noted above for compound 10 is at
odds with the literature.9 However, the sense of the
rotation we report herein is in keeping with that of the
corresponding pentafluorophenyl ester.21
3.3. N-(9-Fluorenylmethoxycarbonyl)-(2-acetamido-2-de-
oxy-3,4,6-tri-O-acetyl-b-D-glucopyranosyl)-L-serine (9)
A mixture of 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-a-
-glucopyranosyl chloride (1, 181 mg, 0.50 mmol) and
commercial N-(9-fluorenylmethoxycarbonyl)- -serine
D
L
(7, 82 mg, 0.25 mmol) in 1,2-dichloroethane (1.5 mL)
was treated as described for the preparation of 5. The
reaction mixture was washed with aq soln of 3% EDTA
and the organic layer dried over MgSO4 and concen-
trated. The residue was eluted from a column of silica
gel with CHCl3–AcOH (8:0.3 and then 8:0.6) to give
the product 9 (83 mg, 50%) as an amorphous solid; [h]D
−14.8 (c 0.29, CHCl3)(Lit.,13c [h]D −14.7); Rf 0.45
[CHCl3–MeOH–AcOH (8:1:0.1)]; lH (CDCl3/CD3OD,
400 MHz) 7.78 (2 H, d, J 7.3, Fmoc Ph), 7.64 (2 H, d,
J 7.6, Fmoc Ph), 7.43–7.31 (4 H, m, Fmoc Ph), 5.20 (1
H, t, J2,3 9.8, H-3), 5.02 (1 H, t, J3,4 9.8, H-4), 4.63 (1
H, d, J1,2 8.6, H-1), 4.49 (1 H, dd, J 10.6, J 6.5,
CH2aFmoc), 4.43–4.41 (1 H, m, CH Ser), 4.39 (1 H, dd,
J 10.6, J 6.8, CH2bFmoc), 4.27–4.17 (2 H, m, H-6, CH
Fmoc), 4.19 (1 H, dd, J 10.9, J 4.0, CH2a Ser), 4.12 (1
H, dd, J5,6% 2.1, J6,6% 12.2, H-6%), 3.89 (1 H, dd, J 10.9, J
3.3, CH2b Ser), 3.84 (1 H, dd, J1,2, J2,3, H-2), 3.69 (1 H,
ddd, J4,5 9.1, J5,6 4.5, J5,6%, H-5), 2.08, 2.03, 2.02, 1.86
(12 H, 4×s, COCH3); lC (CDCl3/CD3OD, 100 MHz)
172.0, 171.1, 170.6, 169.8 (COCH3), 160.5 (CO Fmoc),
143.7, 141.2 (Cquat), 127.7, 125.0, 119.9 (CH Ph),
100.7 (C-1), 72.5 (C-3), 71.7 (C-5), 69.0, 68.8 (C-4, CH2
Ser), 67.0 (CH2 Fmoc), 62.1 (C-6), 54.2, 54.0 (C-2, CH
Ser), 47.1 (CH Fmoc), 22.4, 20.5, 20.4 (COCH3). ES-
IMS found m/z 674.2557 [M+NH+4 ]. Calcd for
C40H44N2O13·NH4 674.2561.
Acknowledgements
These studies were supported by the MRC and the
Weston Foundation. Support in the form of a research
leave fellowship from FAPESP is gratefully acknowl-
edged (IC). We thank Julia Bilke for performing some
preliminary glycosylation experiments. We are indebted
to the EPSRC Mass Spectrometry Service Centre,
Swansea for invaluable support.
References
1. Wells, L.; Vosseller, K.; Hart, G. W. Science 2001, 291,
2376–2378.
2. Zachara, N. E.; Hart, G. W. Chem. Re6. 2002, 102,
431–438.
3. Thornton, T. M.; Swain, S. M.; Olszewski, N. E. Trends
Plant Sci. 1999, 4, 424–428.
4. Comer, F. I.; Hart, G. W. Biochemistry 2001, 40, 7845–
7852.
5. Ohnishi, Y.; Ichikawa, M.; Ichikawa, Y. Bioorg. Med.
Chem. Lett. 2000, 10, 1289–1291.
6. Ohnishi, Y.; Ichikawa, Y. Bioorg. Med. Chem. Lett. 2002,
12, 997–999.
3.4. N-(9-Fluorenylmethoxycarbonyl)-(2-acetamido-2-de-
oxy-3,4,6-tri-O-acetyl-b-D-glucopyranosyl)-L-threonine
(10)
7. Wells, L.; Gao, Y.; Mahoney, J. A.; Vosseller, K.; Chen,
C.; Rosen, A.; Hart, G. W. J. Biol. Chem. 2002, 277,
1755–1761.
8. For example: (a) Garg, H.G.; Jeanloz, R.W. Carbohydr.
Res., 1976, 49, 482–488; (b)Vafina, M.G.; Kim., A.;
Molodstov, N.V. Carbohydr. Res., 1978, 64, 334–338.
9. Arsequell, G.; Krippner, L.; Dwek, R.; Wong, S. Y. C.
Chem. Commun. 1994, 2383–2384.
A mixture of 2-acetamido-2-deoxy-3,4,6-tri-O-acetyl-a-
-glucopyranosyl chloride (1, 181 mg, 0.50 mmol) and
commercial N-(9-fluorenylmethoxycarbonyl)-
threonine (8, 86 mg, 0.25 mmol) in 1,2-dichloroethane
(1.5 mL) was treated as described for the preparation of
9. The residue was eluted from a column of silica gel
with CHCl3–AcOH (8:0.3 and then 8:0.6) to give the
product 10 (67 mg, 40%) as an amorphous solid; [h]D
D
L-
10. Reviewed in Taylor, C. M. Tetrahedron 1998, 54, 11317–
11362.